-
Exploring the Complementary Role of Traditional Chinese Medicine in Enhancing Percutaneous Coronary Intervention Outcomes: Mechanisms, Benefits, and Future Research Directions
10 Jul 2025 09:19 GMT
… Medicine”) and (“Percutaneous Coronary Intervention” AND “Chinese Herbal Drugs”). Randomized controlled trials … .33 Another trial revealed that treatment with Xinyue … molecular pharmacology? Pharmaceuticals. 2022;15(7 … capsule, and ticagrelor on patients with …
-
Advances in the Clinical Use of Clopidogrel: A Review of Individualized Treatment Strategies and Monitoring Optimization Based on Genetic Polymorphisms
09 Jul 2025 13:50 GMT
… use. As the precision medicine paradigm advances, dynamic dose … meta-analysis of six trials involving a total of … the US Food and Drug Administration (FDA) recommended that individuals should … Impact of Dyspnea after Ticagrelor Treatment and the Effect of …
-
Integrity Concerns in Ticagrelor Trials Challenge Clinical Confidence
07 Jul 2025 14:05 GMT
… emerged over the trial data supporting ticagrelor (Brilinta; AstraZeneca), … FDA, despite being included in the published versions of the trials … the drug’s effects.1
Ticagrelor is an antiplatelet medication … when the drug is discontinued.
“If doctors had known …
-
Ticagrelor Market Analysis 2025 – Insights For Long-Term Investment & Planning
04 Jul 2025 08:16 GMT
… medicine, expanding healthcare expenditure, a rise in demand for minimally invasive treatments … report/ticagrelor-global-market … Pharmaceuticals Limited, Alkem Laboratories, Alembic Pharmaceuticals Limited, CCL Pharmaceuticals … 2 By Drug Class: Antiplatelet …
-
Platelet Membrane-Coated Poly (Lactic-Co-Glycolic Acid) Nanoparticles as a Targeting Drug Delivery System for Multidrug-Resistant Breast Cancer
01 Jul 2025 22:18 GMT
… 1:1000 dilution; Santa Cruz Biotechnology, Inc., Dallas, TX, USA … 1:1000 dilution; Santa Cruz Biotechnology, Inc., Dallas, TX, USA … potential application in the treatment of drug-resistant cancers. The … and oral bioavailability of ticagrelor. Int J Pharm. …
-
Scientists Uncover New Concerns About Billion-Dollar Heart Drug
29 Jun 2025 17:16 GMT
… the drug’s approval by the FDA.
For over ten years, ticagrelor (sold … was not involved in the trial, and most investigators, including the … bleeding. If doctors had known what happened in these trials, they would …
-
Urgent warning over drug taken by millions – as AstraZeneca accused of ‘misreporting’ safety data
21 Jun 2025 18:39 GMT
… and Drug Administration (FDA) used to approve the drug.
In order for ticagrelor to get approved, clinical trials … at the start of treatment.
The main side effects of ticagrelor are getting out of … , may then be prescribed by doctors for up to a further …
-
BMJ investigation raises new concerns over ticagrelor approval trials
21 Jun 2025 13:19 GMT
… in the trials were not present in US Food and Drug Administration (FDA) datasets … .
What's more, one active trial investigator … after ticagrelor making patients prone to thrombosis or bleeding. If doctors had …
-
AstraZeneca’s deadly deception: Heart drug Brilinta exposed as ineffective, increasing heart attack risks
20 Jun 2025 21:27 GMT
… medical experts are sounding the alarm over Brilinta (ticagrelor), a blood-thinning drug … drug. The company’s COVID-19 vaccine … trial data. "If doctors had known what happened in these trials … latest proof that pharmaceutical companies cannot be …
-
Top medics issue urgent warning over heart drug taken by millions - as makers AstraZeneca are accused of 'misreporting' safety data
20 Jun 2025 00:14 GMT
… , top doctors have warned.
Anti-clotting pill ticagrelor was approved … whether a treatment is effective—for both trials were … US medicine';s regulator, the Food and Drug Administration (FDA) used … 3 trial.
After phase 3 and drug approval, the FDA and …
About
© 1995-2025